CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Aventis Pharma Limited Company Snapshot
Business Description:
Aventis Pharma Limited operates in the Pharmaceutical preparations sector. Aventis Pharma Limited provides medicines for the treatment of patients in several therapeutic areas: cardiology, thrombosis, oncology, diabetes, central nervous system and internal medicine. Its product include Cardace, Lasilactone, Lasix, Sitelodip, Sitelol AM, Sitelol XR, Sitestat, Telsite, Clexane, Amaryl, Apidra, Apidra, Cetapin P, Cetapin XR, Daonil, Insuman, Lantus, Trental 400, Glimsite, Mesite XR, Rejusite, Vogsite MD, Granocyte, Taxotere, Allegra, Avil, Cosavil Flu, Levohext, Frisium, Proctosedyl, Sofradex, Soframycin, Analgesics, Baralgan, Combiflam, Combihext, Hextradol, Novalgin, Brodactam, Cefrom, Claforan O, Hostacycline, M-Nem, Ornidohext, Quinhext, Rulide AZ, Tacehext, Targocid, Tarivid, Tavanic, Actonel, Arava, Baralgan D, Festal N, Nausehext and Prazohext. Aventis Pharma Limited and Sanofi-aventis holds 60.4% of its paid-up share capital. On November 3, 2011, it acquired Universal Medicare Private Limited. In our complete report available for purchase the company is compared to: Ankur Drugs And Pharma Limited, Alembic Ltd and Ind-Swift Laboratories Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Aventis Pharma Limited
  Stock Performance Chart for Aventis Pharma Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (2/10/2012): 2,193.40
(Figures in Indian Rupees)
1 Week -2.5%   13 Weeks -3.3%  
4 Weeks -6.1%   52 Weeks 21.8%  
 
Aventis Pharma Limited Key Data:
  Ticker: 500674 Country: INDIA
  Exchanges: OTH Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 10,849,521,000
(Year Ending Jan 2011).		 Employees: 2,282
  Currency: Indian Rupees Market Cap: 50,515,366,295
  Fiscal Yr Ends: December Shares Outstanding: 23,030,622
  Share Type: Ordinary Closely Held Shares: 13,910,496
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.